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ABSTRACT
ANALYSIS OF TISSUE ENGINEERING STRATEGIES
FOR BONE-RELATED APPLICATIONS
by
Timothy Buirkle
Over the past few decades, tissue engineering approaches have pushed their way to the
forefront of biotechnological research and development, serving a wide variety of
applications. This research utilizes quantitative methods to analyze the outcome of two
bone tissue engineering studies. In an in vivo study, the use of Negative Pressure Wound
Therapy (NPWT) in combination with stem cell-loaded scaffolds was investigated for the
repair of large bone defects. Quantitative histological analysis was performed by
determining both the percentage of cells proliferating (BrdU), as well as cells expressing
bone-specific markers of alkaline phosphatase (ALP) in the defect. Total cell number in
the defect was also determined by nuclear staining (DAPI). The results at week 1
indicated that the NPWT significantly increased cell numbers – compared to the nontreated control samples – within the defect. As a result, a direct correlation could be
attributed between the use of NPWT and increased bone formation.
In a second study, tissue engineered scaffolds were evaluated for the cell adhesion
and growth of mesenchymal stem cells (MSCs) and breast cancer cells (BCCs). These
scaffolds were investigated for use as a potential in vitro model to examine breast cancer
cell dormancy in the bone/bone marrow microenvironment. Fibrous scaffolds, consisting
of poly-ε-caprolactone (PCL), tricalcium phosphate (β-TCP), or hydroxyapatite (HA),
were fabricated using electrospinning techniques. The β-TCP and HA components are
soluble and stable forms of calcium phosphate respectively, and closely mimic the

physiochemical properties of bone during active bone remodeling. Quantitative image
analysis was performed using scanning electron microscopy images to determine fiber
morphology, fiber diameter, and the degree of fiber alignment. These scaffolds consisted
of either random or aligned fibers. Observations utilizing confocal microscopy identified
MSC and BCC attached to the materials, and MSCs elongated along the aligned fibers.
PicoGreen proliferation assay determined that all scaffolds supported the growth of
MSCs over a two week period. The results demonstrate that the fibrous scaffolds may be
a suitable three-dimensional substrate to examine BCC and MSC interaction. In
summary, this thesis demonstrates the successful use of quantitative analyses in the
characterization and outcome of two bone tissue engineering applications.
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CHAPTER 1
INTRODUCTION

1.1

Tissue Engineering Applications

Tissue Engineering: an at times ambiguous term that has been partially defined by
prominent researchers Langer and Vacanti as “an interdisciplinary field that applies the
principles of engineering and life sciences toward the development of biological
substitutes that restore, maintain, or improve tissue function or a whole organ” [1]. As
engineers firstly, this definition appears to elude to the construction of biological tissues;
however, expanding the term to include “understanding the principles of tissue
growth”[2] allows for scientific methodology of research to be applied. Based upon these
supplementary definitions, tissue engineering is not only the engineering of tissue and
organs for therapeutic treatments, but also the study of the tissue development process in
the body.
Regardless of the intended purpose, tissue engineering consists of three key
factors: cells (the building blocks that ultimately make up any living tissue system), a
three-dimensional matrix (scaffold) on which to seed the cells, and growth factors in
order to induce cell proliferation and guidance towards the intended tissue type [3].

1.1.1 Treatment for Disease/Trauma
Bone tissue engineering can prove to be a vital supplementary component towards
treating a variety of medical conditions for patients. Diseases such as osteosarcoma and
osteoporosis are prevalent ailments affecting individuals of all ethnicities and genders.
Osteoporosis alone affects approximately 40% of white women in the United States, and
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is expected to reach annually estimated costs of $25.3 billion by 2025 [4]. In addition to
disease, there are numerous trauma-related conditions such as the 6.8 million annually
recorded bone fractures in the US [5]. Currently, 2.2 million bone graft procedures occur
annually worldwide, with roughly 600,000 occurring in the US alone [6]. These grafts
aide in the treatment of complex fractures as well as natural defects.
Bone grafts can originate from a variety sources such as autologous (patient’s
bone), allograft (donor bone), or a synthetic variant. As the aging population continues to
grow worldwide due to technological advances in surgical procedures and increased life
expectancies, the rise in reconstructive orthopaedic surgeries will as well. This increase
has led to a heightened demand for bone grafts that far exceeds supply [3]. As a result,
more attention and research has been placed in designing synthetic biomimetic bone
grafts, which are cost efficient, osteoconductive/osteoinductive, contain mechanical
properties similar to native bone, and less invasive than harvesting autologous bone.
These grafts are biocompatible, and in some case enhance bone regeneration

1.1.2 Analyzing Cellular Mechanisms
Engineered bone tissues can serve an important role in studying and analyzing complex
cellular mechanisms during development. Acting as biomimetic scaffolds, these tissues
provide an artificial environment that simulate interactions occurring naturally within the
body. As a result, researchers are able to apply histological techniques on samples as
opposed to human subjects.

3
1.2

Three-Dimensional Scaffold Fabrication

Biomaterial 3-dimensional scaffolds are heavily replied upon in the biotechnology arena
for both research and developing therapeutics. For tissue engineering, scaffolds can act as
delivery systems for tissue-manipulating proteins and cells, as well as provide platforms
in which to grow various cell types. Many factors need to be considered when
constructing a particular scaffold, depending upon the desired tissue.

Chemical

properties, surface chemistry, topography/architecture, and even the mechanical
properties.

1.2.1 Electrospinning
The concept of electrospinning has existed for centuries, first conceptualized by William
Gilbert in the 16th century[7]; however, it was not until the early 1990’s where
researchers such as Reneker and Rutledge began spinning nano-sized fibers from
synthetic polymers. These advancements sparked a boom in the field of medical research,
as scientists sought to utilize the electrospinning process as a scaffold fabrication
approach in tissue engineering, due mainly in part to similarities in architecture [8].
A favorable aspect of electrospinning is the collection of nanofibers to create a
high volume to surface area ratio, which is favorable for cell attachment. For example, at
the Seoul National University in the Republic of Korea [9], researchers investigated the
biological properties of nanofibrous polymer scaffolds with a significant concentration of
interconnected pores (high porosity) against a solid-walled scaffold. Findings in an in
vitro study with cultured osteoblasts revealed elevated levels of biomineralization,
alkaline phosphatase (ALP), and osteoblast phenotype expression for the electrospun
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scaffolds versus the solid-walled. Therefore, scaffold porosity and architecture appears to
play a vital role in bone formation and osteoblast differentiation.
While inter-fiber spacing in general is a helpful component to electrospun
scaffolds, the individual orientation of the nanofibers themselves may further enhance the
biological properties such as the cells’ adhesion [10, 11] and morphology [12], migration
[13, 14], and even differentiation [15, 16]. In an experiment conducted at the Tsinghua
University in Beijing, China, Dr. Wang et al. [17] examined the differential effects of
aligned

electrospun

poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)

(PHBHHx)

scaffolds on MSCs. Confocal microscopy revealed that most attached MSCs elongated
along the fibers as opposed to random fiber samples. Transcriptome microarray results
showed a significant reduction in the PPAR signaling pathway for aligned fibers,
suggesting enhanced osteogenesis. RT-PCR and western blotting also confirmed
osteogenic differentiation with the MSCs for the aligned scaffolds, demonstrating that
fiber orientation plays a role in mediating stem cell fate.

1.2.2 Importance of Materials
Many factors must be considered in selecting an appropriate material(s) for tissue
engineering scaffolds such as the mechanical/physical properties, intended purpose,
degradation rates, biocompatiability, immunogenic properties, and effect on surrounding
environment to name a few. Numerous types of biomaterials, which incorporated into
manufacturing scaffolds designed for bone tissue engineering, can be broken down
largely into two main groups: polymers and ceramics.
1.2.2.1 Polymer-Based Scaffolds.

Polymers are a chief component for many scaffolds,

which have been used for a variety of tissue engineering purposes including bone, neural,
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cardiac tissue regrowth. In recent years, a particular group of polymers – aliphatic
polyesters – have gained large momentum in scaffold fabrication. Some of the more
commonly used polyesters include poly(lactic-co-glycolic acid) (PLGA), poly(εcaprolactone) (PCL), and poly-L-(lactic-acid) (PLLA).
Solely-based polymer scaffolds are able to provide suitable conditions for
numerous tissue engineering applications such as neuronal [18-21], cardiac [22-24], and
liver [25, 26]; however, many research reviews and articles point out the need for ceramic
and/or composite scaffold materials for applications such as bone tissue engineering [8,
27].
1.2.2.2 The Use of Bioactive Ceramics for Scaffolds.

To push beyond providing a

stable support structure that can be easily manipulated to fit the desired mechanical and
morphological inputs, many researchers are turning towards ceramics that exhibit
bioactive properties, which work to manipulate the tissue environment in situ.
Particularly in bone tissue engineering, ceramic components have drawn considerable
attention due to their osteoinductive/osteoconductive tendencies in bone regeneration [28,
29]. Of the various ceramic materials used in bone tissue engineering, two particular
ceramics are used due to their favorable biological properties.
Hydroxyapatite (HA) [Ca10(PO4)6(OH)2], considered one of the most stable forms
of calcium phosphate, is a major component in bone (up to 65%). Furthermore, HA is
known to be osteoinductive, and thus has been used as scaffolding in numerous 3-D
tissue engineering experiments in conjunction with other components – chitosan,
collagen, PLGA – which promote osteogenetic behavior in MSCs [30, 31]. In
experiments by Ugo Ripamonti (University of Witwatersrand, South Africa), the
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osteoinductive capabilities of porous hydroxyapatite (HA), created by hydrothermal
conversion of coral, were observed in vivo in baboons. Histological analysis confirmed
the presence of new bone formation in subjects three months post-surgical implantation.
These results were attributed to not only the chemical makeup of HA, but also due to the
porous morphology of the scaffold, which encouraged localized cell ingrowth [32].
β-Tricalcium phosphate (β-TCP) [Ca3(PO4)2] is a commonly used alternative to
HA, which has been FDA approved in several bone products such as Vitoss (Orthovita),
Mastergraft® (Medtronic), Chronos® (Synthes), Calciresorb® (Ceraver Osteal), and
Biosorb® (SBM France) [33, 34]. In addition to its demonstrated osteoconductive
properties, implanted β-TCP has a relatively high rate of degradation that allows for bone
remodeling in vivo [35, 36].
As both β-TCP and HA have competing advantages for use in bone tissue
engineering, several companies have sought products combining both components, such
as Nuvasive’s Formagraft® (60/40 β-TCP/HA) and Stryker’s BoneSave® (80/20 βTCP/HA) [3, 36]. In studies performed by Dr. Arinzeh et al. [37] in vivo mouse testing
was conducted to determine the ideal ratio of HA/β-TCP. Ceramic scaffolds were
constructed comprised of varying concentrations of β-TCP/HA. Histological testing
revealed 80/20 β-TCP/HA scaffolds seeded with hMSCs resulted in superior rates of
bone induction compared to competing compositions. Furthermore, in vitro osteocalcin
assays confirmed elevated expression levels indicating osteogenic differentiation of
hMSCs.
1.2.2.3 Combining Characteristics with Composite Scaffolds.

While

certain

bioceramics show great osteoconductive and osteoinductive potential for bone regrowth,
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when used individually they are far too brittle and fail to provide the needed structural
support [29, 38]. Therefore, a focus has shifted towards the use of composite scaffolds,
which consist of polymers as well as bioceramics in an effort to combine the advantages
for both. While the ceramic elements proportionally increase bioactivity [39], the
biodegradable synthetic polymer aims to provide elasticity and tensile strength [40]. In
experiments by Lao et al. [41] at the Zhejiang University in Hangahou, China, the
polymer PLGA was electrospun from a solution coupled with nanosize hydroxyapatite
particles (HAp) in an effort to combine the mechanical advantages of a polymer along
with the bioactive potential of ceramic. When tested in vitro with cultured mice MC3T3
preosteoblast cells, ALP secretion was significantly enhance by the composite scaffolds
as compared to the PLGA controls. Similar results were also found utilizing a degraded
polymer gelatin (a derivative of collagen) as a natural substrate with HA [42].
Several studies have indicated that the combined use of both β-TCP and HA in an
80/20 ratio for electrospinning fibrous mats offers a superior abilities to promote bone
tissue formation compared to other concentrations [43, 44].

1.3

Cell and Tissue Analysis

In order to demonstrate a superiority of one material’s use over another or to prove the
existing benefits of a process in tissue engineer, a variety of analytical methods must be
applied. Furthermore, these methods must act as tools to support the proposed theoretical
claim.
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1.3.1 Qualitative Analysis: Immunostainings and SEM
Immunocytochemistry is a fundamental aspect of tissue engineering research, as it
applies an antibody-based method to detecting a given protein within a sample. After
which, a variety of optical methods are called upon to detect. This can be very useful
when trying to highlight certain cell processes (differentiation [45-47], proliferation [48,
49], viability) or the components within the extracellular matrix of a tissue sample
(immunohistochemistry). These stainings can track the rate of change of a protein over
time, as well as provide for comparative analysis between competing methods and
techniques. Additionally, immunostainings can typically provide qualitative results in
procedures utilizing epifluorescence/confocal microscopy.
Optical microscopy is a commonly used technique by researchers to provide a
visual representation of the experiment results that support an experimental claim
(hypothesis). When coupled with immunostainings, epifluorescence and confocal
microscopy and allow for detailed high magnification imaging of cellular components to
portray cell morphology and/or to demonstrate the presence of specific genes or proteins.
Ordinarily, proteins that have forgone the immunostaining process will fluoresce when
placed under a light-emitting diode at a particular excitation wavelength.
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Figure 1.1 Epifluorescent image of a dividing cancer cell. DNA (blue) is stained by
DAPI, protein GFP-INCENP (green), and tubulin (red). The bottom right image contains
the combined rendered picture of all three images [50].

These wavelength images can then be overlaid to create a detailed image
portraying several different markers. In Figure 1.1 for example, three images were
captured at different wavelengths and compiled to illuminate cell structures of a human
cancer cell undergoing cell division [50].
Unfortunately, there are several drawbacks of epifluorescence, one of which being
a three-dimensional structure can only be in focus from one given plane. In the case of
tissue engineering on scaffolds, a similar method known as confocal microscopy is used
in order to obtain images with higher clarity and resolution. Using a system of lasers,
multiple planed images are taken at different depths of the scaffold and then compiled to
form a three-dimensional version, also known as a z-stack (Figure 1.2).
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Figure 1.2: Description of the z-stack process in which a compilation of planed images
can render a three-dimensional object [51].

While confocal imaging can generate a three-dimensional picture of the target
proteins, it still lacks the ability to generate a clear image of the scaffold’s topography; a
technique called scanning electron microscopy (SEM) is used in order to accomplish this.
As the name suggests, SEM directs a beam of electrons at the intended sample,
registering highly magnified images with a resolution superior to optical imaging (Figure
1.3). Whether a confocal or an epifluorescence is used, the resultant image is primarily
used for illustrative purposes. When comparing biomolecular processes, additional
testing is typically followed in order to obtain quantitative results that provide more
concrete evidence.
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Figure 1.3 Sample SEM image taken of a PCL nanofiber scaffold [52].
1.3.2 Quantitative Analysis
Quantitative data provides a concrete objective analysis for an experiment, enabling the
research team to draw conclusions more readily than through visual examination as in
imaging techniques. Typically, quantitative analysis is conducted with greater ease in
experiments in vitro since the entire sample can be analyzed as opposed to the entire
subject of an in vivo experiment. In vitro studies allow for more control over variables
such as the ECM components in media. For example, Polini et al. [53] at the National
Nanotechnology Laboratory in Lecce, Italy utilized several assays in order to test the
osteoinductive capabilities of several different scaffolds composed of combinations of
PCL, HA, and β-TCP. When conducting in vitro testing with seeded hMSCs, quantitative
proliferation assays revealed consistent growth curves over a six day period. In addition,
Polini’s team used semi-quantitative image analysis in determining ALP levels to denote
osteogenic differentiation. The term “semi-quantitative” is appropriate in this case since
ALP levels were obtained by converting the stained images to grey-scale, highlighting
the region of interest (ROI) containing the visible ALP, and then recording the mean
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intensity value (Figure 1.4). Therefore, when comparing levels of ALP expression among
scaffold types, judgments are based upon image brightness as opposed to the actual
numeric quantity of ALP.

Figure 1.4 Graph of signal intensities within the ROI of ALP-stained images for various
scaffold types and compositions [53].

CHAPTER 2
RESEARCH OBJECTIVES

The following research investigated and analyzed bone tissue engineering strategies for
bone repair and cancer applications using various quantitative immunohistological and
immunocytochemical techniques. First, several immunohistological techniques were
applied to an in vivo model involving the use of bioactive ceramic scaffolds,
mesenchymal stem cells, and vacuum assisted closure (VAC) therapy to repair a rabbit
radial defect. The goal of this study was to analyze and compare experimental treatments
in order to determine which strategy would prove to be the most effective. In order to
analyze the contribution of the mesenchymal stem cells and other host cells in bone
repair, immunostaining was performed for specific protein markers to observe cell
proliferation as well as osteogenic differentiation. The purpose of this bone defect study
was to determine whether the use of VAC in combination with the scaffolds and MSCs
would improve repair as compared to groups without VAC therapy.
A second study investigated the bioactive properties of fabricated biomimetic
bone tissue scaffolds. Previous research has denoted the benefits of fiber orientation as a
means of enhancing cellular behavior. The goal of this study was to create aligned
electrospun scaffolds whose components would mimic the physiochemical properties of
bone. Cell attachment and cell proliferation were analyzed using immunostaining
techniques. The hypothesis of this work was that the aligned fiber scaffolds would
demonstrate an increased cell attachment, osteogenic differentiation, and cell viability.
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CHAPTER 3
IMAGE ANALYSIS FOR IN VIVO STUDY

3.1

Experimental Set-Up

The following study provides an inside look into the utilization of tissue engineering for
the purpose of developing novel medical treatments – bone regeneration in patients who
have underwent orthopaedic surgery in response to trauma, reconstruction, or skeletal
defects. More specifically, immunohistochemical analysis was performed for an in vivo
preclinical trial on rabbits to test the effects of a potential treatment – vacuum-assisted
closure (VAC), which is a form of negative pressure wound therapy used to aide in would
closure [54, 55]. Therefore, this experiment tested the effectiveness of VAC therapy in
conjunction with orthopedic surgical techniques.
Prior to experiments, the rabbits were divided into two main groups: those
receiving NPWT treatment, and those that did not undergo therapy. In order to evaluate
the potential use for NPWT conjointly in implant/graft surgeries, the two main groups
were each divided into the following three subgroups: subjects that received an implant at
the defect site, subjects that received an implant seeded with marrow-derived rabbit
mesenchymal stem cells (MSCs), and subjects who had no implant (control). Lastly, each
subgroup was divided further into two post-surgery evaluation groups – Week 1 and
Week 8 - in order to track both the short and long-term effects of the given treatments.
Each specific group had a sample size of four to allow for statistical significance.
In the surgical procedures, New Zealand White rabbits were each given a 1.5 cm
segmental defect along the radius. The corresponding groups then received varying
combinations of treatment involving NPWT and implantation of the synthetic porous
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graft (60/40 w/t hydroxyapatite/beta-tricalcium phosphate) with or without seeded MSCs.
Including the main treatment (VAC), secondary treatments (implant or MSC-implant),
and controls, there were a total of six treatment groups. Each rabbit subject was then
sacrificed according to its designated evaluation group and then prepared for
histomorphometry and immunohistochemical analysis.

3.2

Materials and Methods

3.2.1 Cellular Protein Stainings
In order to demonstrate and compare the rates of bone regrowth for the rabbit subjects,
both the cell proliferation and osteogenic differentiation percentages needed to be
calculated. In order to achieve this, three immunostainings were performed. The synthetic
nucleoside 5-bromo-2’-deoxyuridine (BrdU) (Sigma) was chosen as an immunostaining
to highlight proliferating cells based upon previous study successes [48, 49]. A solution
containing Fast Red TR/Naphthol (FR/NAP) (Sigma-Alderich) was added in which
bound to alkaline phosphate (ALP) that was present in the defect sites during
osteogenesis. Lastly, DAPI – a nuclear stain for all cell types – was used to calculate the
total cell numbers in a sample for the purpose of calculating the proliferation and
differentiation percentages.
In preparation for staining, all histological samples were first removed from the
freezer and hydrated in a 400µl solution of Dulbecco’s Phosphate Buffered Saline (PBS)
(GIBCO) for twenty minutes at room temperature (RT). After decanting the PBS and
carefully wiping the sides of the slide, a hydrophobic barrier was applied around the
edges of the sample using a Super PAP Pen Liquid Blocker (Ted Pella) in order to reduce
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the required solution volumes per sample and to prevent spilling during storage and
imaging. For all staining procedure steps, samples were incubated at RT unless otherwise
specified.
3.2.1.1 ALP Staining for Differentiation. Before staining, a solution of AP Buffer was
prepared, consisting of 100mM tris(hydroxymethyl)aminomethane hydrochloride (TrisHCl), 100mM sodium chloride (NaCl) (Sigma), and 5mM magnesium chloride (MgCl2)
in distilled water (dH2O). Histological samples were decanted of PBS, wiped clean
(Kimberly-Clark Kimwipes), and soaked in 400µL AP Buffer for five minutes to better
prepare the tissues for staining. Next, the AP Buffer is decanted, and the slide wiped dry.
Then, 400µL of 1:100 FR/NAP in AP Buffer were added for 12-15 minutes. This step
was performed in a minimal light environment to prevent overexposure of the Fast Red
TR. After a maximum of 15 minutes in which ALP was visibly present in red, the slides
were rinse with 10mL of PBS, at which point the ALP staining was complete.
3.2.1.2 BrdU Immunostaining for Proliferation. When

immunostaining

for

cell

proliferation, monoclonal anti-BrdU was used in conjunction with a secondary
fluorescent antibody – goat anti-mouse FITC conjugate (FITC) (Abcam). Anti-BrdU
formed attachments to BrdU, which would replace thymidine nucleosides in newly
synthesized DNA strands during a cell’s S-Phase. The secondary antibody, FITC, would
attach to anti-BrdU and highlight proliferating cells by fluorescing at 528nm (green).
Fixed samples that were already hydrated in PBS were decanted and wiped drip.
A 400µL solution – 0.1% Pepsin (ACROS) in (0.1 molar concentration (M) HCl in PBS)
– was first applied. The samples were placed into an Isotemp 120 (Fisher Scientific)
humidified chamber at a temperature of 37°C for a 50 minute incubation period. The
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slides were then decanted and wiped again, and set in a 400µL 2M of HCl in dH2O.
Thirty minutes of incubation in the Isotemp allowed just enough time for the HCl to
permeablize the cells’ membrane and denature the DNA, but without damaging the cells
to the extent of being unrecognizable. Afterwards, the slides were thoroughly rinsed with
50mL of PBS and checked for pH levels ~7.0 (neutral acidity level for water). If the pH
level was six or lower, then the rinse process was repeated. Prior to antibody treatment,
the cells were blocked using a solution of 5% normal goat serum (NGS) in (1% bovine
serum albumin (BSA) in PBS) for one hour. The samples were then ready to begin
antibody exposure.
The primary antibody, monoclonal anti-BrdU (Sigma-Alderich), was mixed
1:1,000 in a solution of 1% NGS in (1% BSA in PBS). Following decantation and
wiping, 400µL of solution were applied, and samples were placed in a humidified
chamber to store overnight at 4°C. On day 2 of the staining, slides were removed from
the chamber and soaked three times in 400µL PBS for ten minutes. After decanting and
wiping, the secondary antibody FITC was mixed 1:500 in a solution identical to antiBrdU and applied for one hour in darkness. Lastly, the slides were rinsed three times in
PBS for five minutes each, and stored in 500µL PBS in the humidified chamber at 4°C
until needed for analysis.
3.2.1.3 DAPI Nuclear Stain for Cell Population. All slides underwent a DAPI stain
just prior to imaging in order to visualize the total present cells per sampling. Initially,
200µL of PBS were applied, followed by two drops of SlowFade® Gold antifade reagent
with DAPI (Invitrogen). The solution was then decanted, the slide was wiped clean, and
300µL of PBS were added.
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3.2.2 Fluorescence Microscopy
After the samples were appropriately stained, fluorescence microscopy was run using
NIS-Elements AR 3.2 software (Nikon). Three fluorescent lightings were used at 10x
magnification for these experiments: red (ALP), green (FITC/BrdU), and blue (DAPI).
Samples for week 1 were imaged for all three components (ALP, proliferation, total cell
population); however, week 8 was only imaged for ALP and total cells (DAPI) since
bone regeneration was complete, ceasing cell proliferation.
For each subject, two adjacently sliced samples were analyzed in which one
sample slide was stained and imaged for ALP and BrdU (depending on sample), and the
other slide for DAPI. Fluorescent images were recorded at identical sample locations in
order to later overlay the two for ALP analysis (section 3.3.1). Images then underwent
denoising to remove any recorded background interference (Figure 3.1).

Figure 3.1 Red-fluorescent image of alkaline phosphatase for week 1 rabbit subject;
image is first captured (A) and then filtered using image denoising (B) in order to provide
more contrast, and perform analysis more efficiently.
In rabbit subjects that only had the defect (no implant and/or MSCs), the
following six images were taken: four images from the corners of the bone/defect site,
and two images from the center of the defect (Figure 3.2). This process allowed for the
comparison of tissue regrowth from several areas in order to ensure a uniform rate
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throughout the sample. Additionally, this method provided consistency and helped to
remove human error in the form of arbitration.

Figure 3.2 Schematic of images taken from the defect area.
3.2.2.1 Object Count for Cell Sample Population.

For determining the number

of DAPI-stained cells and proliferating BrdU-stained cells, the Object Count function
was used, which registered cell presence based upon specified morphology (circularity)
and fluorescent intensity thresholds (Figure 3.3).

Figure 3.3 Cell Count feature for determining sample populations; features picked up in
the intensity threshold range are highlighted in blue; features recognized as cells are
outlined in green.
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3.2.2.2 Regions of Interest (ROIs) for ALP Analysis.

In

order

to

determine

estimated levels of ALP in samples for comparison, percentages were calculated based
upon cell counts. First, one or more ROIs were created using the autodetect feature in
order to (Figure 3.4A) establish the areas of ALP in which to count the cells present.
Next, the red-filtered samples were overlaid with the blue-filtered DAPI images, and a
cell count was performed for cells within the ROI (Figure 3.4B). This was then compared
against sample population count (section 3.2.2.1) in order to get a percentage of ALP
expression.

Figure 3.4 Determining the levels of ALP expression by highlighting ROIs (A) and
counting the number of cells present within the selected area (B); objects recognized by
the Object Count are highlighted (blue), depicting objects counted (green outline) and not
counted (yellow outline).
3.2.3 Statistical Analysis
All quantitative data underwent statistical evaluation in order to determine the presence
any significant differences. More specifically, statistical inference for independent
populations via t-testing was performed with the level of significance, p<0.05.
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3.3

Results and Discussion

The following sets of data and analysis are a compilation of the results of the eight week
experiment involving the defective rabbit radius, which underwent surgical treatment.
The osteoconductive as well as proliferative capabilities are examined in the expression
of ALP and BrdU, respectively.

3.3.1 Osteogenic Differentiation: ALP Expression
Each subject was imaged for both DAPI (blue) and ALP (red) at 10x magnification.
These images were then overlaid to demonstrate when the ALP was expressed in relation
to the viable DAPI-stained cells. Unlike the cell nuclei which can be easily distinguished
from one another, the visualization of ALP had a degree of arbitration. To counteract this,
the background interference was used as a guide to determine the true levels of ALP
picked up by the light emitting diode. For example, in Figure 3.6B the intensity of the red
spectrum was raised to the point of visualizing the background interference in order to
show that no ALP was present within the sample. The contrary can be seen in figure
3.5B, where the expression of ALP is visible despite low levels of background
interference.
The DAPI and ALP+ cell counts were recorded for all images, the percentage of
ALP expression was calculated (adjacent to bone, center of defect, pore site, canal) in
each sample group (n=4), and then the values were averaged for comparative analysis
(Table 3.1). Fluorescent imaging and qualitative analysis showed that for week 1 subjects
the expression of ALP was negligible at both the center of the bone defect and in the
canal of the implant scaffold. Defect only subjects receiving the VAC treatment also
appeared to have higher levels of ALP, although not enough for statistical significance.
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Figure 3.5 Fluorescence microscopy for rabbit subjects receiving no implant (defect
only). Week 1 rabbits were divided into those receiving VAC (D-F) and those without
VAC (A-C). Week 8 subjects were also grouped accordingly with VAC (J-L) and without
VAC (G-I). For each image, ALP (red), excreted from osteogenic cells into the ECM,
appear as cloud-like formations; the DAPI (blue) represents the individual nucleus of
each cell present.
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Figure 3.6 Fluorescence microscopy for rabbit subjects receiving an implant. Week 1
rabbits were divided into those receiving VAC (D-F) and those without VAC (A-C).
Week 8 subjects were also grouped accordingly with VAC (J-L) and without VAC (G-I).
For each image, ALP (red), excreted from osteogenic cells into the ECM, appear as
cloud-like formations; the DAPI (blue) represents the individual nucleus of each cell
present.
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Figure 3.7 Fluorescence microscopy for rabbit subjects receiving MSC-loaded implant.
Week 1 rabbits were divided into those receiving VAC (D-F) and those without VAC (AC). Week 8 subjects were also grouped accordingly with VAC (J-L) and without VAC
(G-I). For each image, ALP (red), excreted from osteogenic cells into the ECM, appear as
cloud-like formations; the DAPI (blue) represents the individual nucleus of each cell
present.
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Table 3.1 Average ALP Data for All Rabbit Groups
Duration/
Treatment

VAC

No VAC
Week 1
Defect Only
With VAC

No VAC
Week 8
Defect Only
With VAC

No VAC
Week 1
Implant
With VAC

No VAC
Week 8
Implant
With VAC

*No VAC
Week 1
Implant
+ MSC

With VAC

No VAC
Week 8
Implant
+ MSC

With VAC

Image Location

% ALP

All Locations
Adjacent to Bone
Center of Defect
All Locations
Adjacent to Bone
Center of Defect
All Locations
Adjacent to Bone
Center of Defect
All Locations
Adjacent to Bone
Center of Defect

4.45±3.14
6.68±4.71
0.00±0.00
7.60±6.32
11.39±9.49
0.00±0.00
22.90±5.94
34.35±8.93
0.00±0.00
18.39±4.57
24.75±5.55
5.66±6.31

All Locations
Pore Site
Implant Canal
All Locations
Pore Site
Implant Canal
All Locations
Pore Site
Implant Canal
All Locations
Pore Site
Implant Canal

3.15±3.57
4.20±4.76
0.00±0.00
1.24±0.76
1.65±1.01
0.00±0.00
26.84±7.08
25.99±8.45
29.38±4.52
24.86±14.12
26.52±14.51
19.89±13.73

All Locations
Pore Site
Implant Canal
All Locations
Pore Site
Implant Canal
All Locations
Pore Site
Implant Canal
All Locations
Pore Site
Implant Canal

0.00±0.00
0.00±0.00
0.00±0.00
0.00±0.00
0.00±0.00
0.00±0.00
9.19±8.10
8.03±8.88
12.12±8.61
10.34±3.75
9.71±4.25
12.23±9.83

Values = mean ± standard deviation; *Week 1 Implant-MSC groups had no significant ALP expression in
cells.
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Subjects receiving the MSC-loaded implant showed no significant levels of ALP
expression at all locations during week 1 (the very select few images which contained
trace amounts of ALP were ruled statistical outliers and discounted from the results).
Theses finding were verified visually by Figure 3.7, in confocal images B and E, which
also show no visible ALP in the pores or canal. At week 8, ALP levels for MSC-loaded
were still recorded at relatively lower levels than for defect or implant only.
Unfortunately, these was a considerable degree of variability overall between samples in
each group, which created high levels of variance (large standard deviations). As a result,
statistical significance between treatments over time was difficult to determine.

3.3.2 Proliferation: BrdU Expression
Each rabbit sample designated for week 1 was stained with BrdU, imaged using
fluorescent microscopy (green), and analyzed using Object Count for proliferating cell
numbers. Each analyzed image group was then compared to determine any significant
differences in tissue regrowth (proliferation). Figure 3.8 displays a BrdU fluorescent
image for each week 1 rabbit experimental group. Sample groups receiving no VAC
treatment (left) were compared against those with VAC (right). Additionally, the
treatments of defect only (A,B), implant (C,D), and MSC-loaded implant (E,F) were
cross-analyzed to determine any variations in the rate of tissue regrowth.
For rabbits groups containing implants (C-F), six images were taken at pore sites
and two images from the implant canal. Non-implant groups (A,B) had four images taken
adjacent to the host’s bone as well as two images at the defect’s center. At pore sites, the
proliferating cells can be seen at the edges and center, indicating tissue regrowth into the
porous implant material.
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In samples that received VAC therapy, there was a statistically significant
difference in the percentage of BrdU-stained cells, indicating high rates of proliferation
compared to controlled samples not receiving the therapy (p<0.05) (Table 3.2). These
differences are observable at both the locations adjacent to the bone as well as at the
center of the defect. Overall, BrdU levels appear to be constant through their respective
samples, regardless of where the image was taken. This demonstrates a uniform level of
tissue regrowth for the sample depending upon the given treatment or therapy.
Table 3.2 Percentage of BrdU Positive Cells for All Week 1 Samples

Defect Only

Implant
Implant
+ MSCs

All Locations
Adjacent to Bone
Center of Defect
All Locations
Pore Sites
Canal
All Locations
Pore Sites
Canal

Control
11.56±4.15
11.22±3.57
12.12±5.03
24.59±14.28
24.81±15.29
23.93±16.81
26.32±5.67
25.67±3.21
28.29±13.46

VAC
*20.81±4.53
*20.41±2.52
21.61±11.06
15.57±5.02
16.48±3.82
12.87±11.29
37.91±18.07
37.07±17.53
40.52±19.84

Value = average ± standard deviation; *Percentage BrdU + cells for defect only samples with VAC were
higher than control group without VAC (p<0.05).
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Figure 3.8 Green fluorescent microscopy images for the following Week 1, BrdU-stained
proliferating cells: defect only samples (A,B), implant (C,D), and MSC-loaded implant
(E,F) receiving either no additional treatment or VAC therapy, respectively.

CHAPTER 4
SCAFFOLD DEVELOPMENT AND ANALYSIS FOR IN VITRO STUDY

4.1

Experimental Set-Up

Previous research has indicated that the cellular mechanisms relating to breast cancer
remission may be linked to mesenchymal stem cells (MSCs) [56]. MSCs are believed to
form intercellular connections via gap junctions with BCCs [57], facilitate their migration
into the bone marrow using chemotaxis [58], and may even provide an exchange of
nutrients to maintain BCC viability. Additionally, MSCs immunogenic properties may
play a factor in preventing the body from attacking these dormant BCCs [59, 60].
This experiment called for a comparative in vitro study in which BCC-lines
(active and dormant) were co-cultured with hMSCs on simulated bone tissue in order to
better simulate the environmental conditions in the body. Bioactive scaffolds were
electrospun using ceramic components natural found in bone such as hydroxyapatite
(HA) and tricalcium phosphate (β-TCP). Synthetic polymer (PCL) was also chosen to
decrease the scaffold’s brittleness and promote more favorable mechanical properties.
BCCs (cell line: MDA-MB-231) were genetically modified to express OCT-4
green fluorescent protein (GFP) when in states of dormancy. As a result, two comparable
cancer cell lines were created when sorted – dormant BCCs with high levels of
expression (OCT4-Hi) and active aggressive BCCs with low levels (OCT4-Lo).
These experiments provided the necessary background work in order to conduct a
thorough study investigating the intercellular connections between these cell types. To
assure these results and methods are sound with minimal outlying variables, testing needs
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to first be performed on a variety of components such as the scaffolds, analytical
components used in immunoassays, and cell-to-scaffold attachment properties.

4.1.1 BCC Attachment and Morphology Study
The first preliminary experiment dealt with BCC attachment to the various scaffold
fibers. While previous studies had shown success in seeding the BCCs onto biomimetic
scaffolds, testing needed to prove that these cells were capable of attaching to theses
specific scaffold types and could easily be distinguishable under confocal microscopy.
For this to be successful, BCCs with both high and low expressions levels of
OCT-4 were each chosen in order to portray quiescent and active cancer cells
respectively. Each cell type was then seeded onto four different random fiber scaffolds at
seeding density of 1000 cells/sample: PCL, PCL/HA, PCL/β-TCP, and aligned PCL
(Table 4.1). Only four scaffolds were chosen for the experiment due to both the cost and
availability of the specific BCC types. For each BCC-scaffold sample, there were three
time duration subgroups at days 1, 2, and 4. Lastly, each subgroup was given a sample
size of 2, in event of there being a discounted sample due to unforeseen abnormalities.
Table 4.1 Plate Layout for BCC Attachment and Morphology Study
PCL

A
B
C
D
E
F
G
H

PCL/β-TCP

PCL/HA

1
Lo
Lo

2
Hi
Hi

Lo
Lo

Hi
Hi

3

4
Lo
Lo

5
Hi
Hi

6

7
Lo
Lo

*This plate layout is representative of one time point only

8
Hi
Hi

9

Aligned
PCL
10
11
Lo
Hi
Lo
Hi

12
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Immunostainings were carried out using DAPI as a nuclear stain, as well as
rhodamine phalloidin to highlight actin formation in the cytoplasm and examine cell
morphology. All cell samples were then examined for expression of GFP, DAPI, and
actin via confocal microscopy, and images were captured using NIS-Elements AR
software (Nikon).

4.1.2 Scaffold-MSC Viability and Morphology Study
This study investigated the bioactive capabilities of aligned fiber scaffolds towards
human mesenchymal stem cells (MSCs) in regards to cell attachment, morphology, and
proliferative viability. MSCs were seeded onto scaffolds of four separate compositions
(see section 4.1.3) with both aligned and random fiber orientations (eight total mat types).
Upon seeding at 1000 cells/sample in general media, samples were analyzed at days 1, 4,
7, and 14 in order to track the scaffold-cell interactions over a two-week period. The
MSC morphology was captured via confocal images of nuclear and actin
immunostainings. Quant-iT™ PicoGreen® dsDNA Reagent quantitatively determined
the cell population for each individual sample.

4.2

Materials and Methods

4.2.1 Scaffold Fabrication
Throughout the BCC-MSC study, two different fiber configurations were examined:
random fiber mats (RM) and aligned fiber mats (AL). For each fiber configuration, four
choices of materials were chosen due to their proven results in experimentation and
demonstrated superior mechanical properties in comparison to other biomaterials. First, a
synthetic degradable polymer material was chosen: 15% w/w PCL dissolved in MC. Two
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other mats were composites, comprised of 10% w/w PCL in MC solution in 30w/w of
either HA or β-TCP. Lastly, a fourth composite mat was investigated, consisting of 10%
w/w PCL in MC solution in a 30% w/w 80/20 blend of β-TCP and HA respectively.
4.2.1.1 Solution Preparation.

Prior to electrospinning, each solution was prepared

using Methylene Chloride (MC) as a solvent, mixed with the desired concentrations of
PCL (Alderich), HA (Berkeley Advanced Biomaterials), β-TCP that act as the solutes.
Prior to adding the ingredients, the vial and stirrer were first rinsed in a MC bath to
ensure there is no residue present from previous trials. The individual solutes were then
weighed out on the electric scale (Ohaus Corporation, USA) based upon desired
concentration and volume of solution – for these experiments, all solutions had a mass of
10 grams. After pipetting the calculated amount of MC, the open solution was placed on
the magnetic stirring plate (Corning). At this point, the PCL beads were then added to the
solution while stirring; this ensured that the magnetic stirrer did not become lodged at any
point. The lid was promptly screwed on tightly afterwards to prevent the fast-evaporating
MC from venting and thickening the solution. After roughly one hour of mixing,
solutions prepared for pure PCL mats were deemed ready for electrospinning after 2
minutes under a digital sonicator (Branson Ultrasonic Corp.) to relieve trapped air and
break apart any remaining particles. For designing composite scaffolds containing
ceramic components, desired amounts of HA and β-TCP were weighed out on the electric
scale, slowly added to the dissolved PCL-MC solution, mixed for two hours, and then
sonicated for 2 minutes before being electrospun. The % w/w of PCL in composites was
reduced (from 15% to 10%) in order to maintain a low enough viscosity to prevent
clogging in the needle when spinning.
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4.2.1.1 Random Mat Electrospinning.

Each prepared solution was loaded into a

either a 10 or 20mL plastic syringe (BD), equipped with either a 12 or 20 gauge needle
for polymer and composite solutions respectively (Table 4.2). For scaffolds composed
only of polymer PCL, a closed environmental chamber was used in order to manipulate
the humidity to the necessary levels needed for spinning (Figure 4.1) Composite-type
scaffolds required an open chamber set-up in which the solution was subject to the
natural temperature and humidity levels, which were recorded at the commencement of
the electrospinning process. As a result, composite scaffolds could only be constructed
during midday under fair-weather conditions in which humidity levels were significantly
lower.
Table 4.2 Electrospinning Parameters for All Scaffold Mat Types
Fiber
Type

Components
PCL

Needle
Gauge
12

Collector
Distance (cm)
40

Voltage
(V)
20kV

Flow Rate
(mL/hr)
7

PCL + Ceramic

20

40

20kV

3

PCL

12

20

20kV

7

PCL + Ceramic

20

20

20kV

3

Random

Aligned

Machine
3rd Floor,
Controlled
2nd Floor,
Open
3rd Floor,
Controlled
2nd Floor,
Open
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Figure 4.1 Diagram of environmental chamber for PCL electrospinning process.
A Harvard Apparatus syringe pump controlled the flow rate of the solution, which
was charged by a current carrying electrode connected to a 20kV DC power source
(GAMMA High Voltage Research). A grounded 8”x8” collecting aluminum plate,
located 40cm from the needle tip, accumulated the randomly oriented fiber strands as
they shot from the syringe (Figure 4.2).
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Figure 4.2 Set-up for random mat electrospinning.

4.2.1.2 Aligned Mat Electrospinning.

For aligned fiber spinning, the majority of

parameters were duplicated from the random mat protocol, such as voltage, needle gauge,
and flow rate (Table 4.2). In this case, the distance was shortened to 20cm as opposed to
40cm in order to increase fiber accumulation efficiency. The collecting plate was
replaced with a foil-covered rotating drum (rotating diameter = cm) (Figure 4.3), kept at a
high RPM of 1,000-1,300 using a Nova-Strobe series stroboscope (Monarch Instrument);
lower RPMs resulted in unaligned fiber mats. Since the surface area was significantly
larger for the drum (A = cm2), 2-3 batches of solution were used for each spin in order to
obtain an aligned mat of relative thickness compared to random mats.
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Figure 4.3 Diagram of rotating drum used for aligned electrospinning.

4.2.2 Scaffold Characterization
4.2.2.1 Visualizing Surface Morphology via SEM.

In order to ensure each

scaffold was created to the desired specifications, scanning electron microscopy (SEM)
(LEO 1530 Gemini) was performed to test for the materials’ fiber distribution, fiber
diameter, and the degree of alignment. SEM served as the ideal tool due to its innate
ability to generate high magnification 3-dimensional images with a superior resolution in
comparison to a conventional microscope. Four samples were taken per scaffold for
testing using biopsy punches (Miltex) to create disks measuring 6mm in diameter. They
were then attached to aluminum mounts (Electron Microscopy Sciences) using doublesided carbon tape. To make the mounted samples conductive for SEM, they underwent a
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gold-palladium coated sputtering process at 40mA for 15 seconds. The coated mounts
were placed in the vacuum-sealed SEM chamber, with an accelerating voltage (electron
high tension or EHT) of 3kV and a working distance (sample surface to lens) of 7-8mm.
Four SEM images were each taken at 500X, 1KX, and 2.5KX, and then were analyzed
using ImageJ software (National Institutes of Health).
4.2.2.2 Calculating Degree of Fiber Alignment.

Fiber alignment was determined by

forming a line perpendicular to a fiber in each 1KX image (ImageJ). Five angle
measurements were then taken at random between the drawn line and fiber, and their
absolute deviation values were recorded (ADV). The following equation illustrates the
needed

calculations

using

the

ADV

for

each

of

the

16

images:

% Alignment = (90° – ADV) / 90° * 100%

(4.1)

4.2.2.3 Analyzing Fiber Thickness. In order to determine the fiber diameter for each
scaffold, 1KX images were examined using ImageJ software. After globally
standardizing the images using the scale bar, measurements were taken for five arbitrarily
chosen fibers. These measurements were averaged for each image, then again for each
scaffold type (20 images/per type) in order to determine the average fiber diameter.

4.2.3 OCT4-GFP BCCs
BCCs, transfected to express the OCT4 green fluorescent protein (OCT4-GFP), were
supplied from several breast cancer patient donors at the University of Medicine and
Dentistry of New Jersey (UMDNJ). Cell sorting yielded two breast cancer cell lines –
those with high and low OCT4 expression levels – which were representative of
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quiescent and active BCCs respectively. This transgene expression allowed for a
straightforward and clear-cut view of the cells when viewed using confocal microscopy.

4.2.4 PicoGreen Cell Proliferation Assay
PicoGreen proliferation assays rely on comparing the absorbance levels of stained
samples to that of known cell populations (standards). Standards were prepared by first
suspending a thawed cryovial containing MSCs into a suspension of ~9mL general
media/106 cells in a sterile environment. Next, the cells were centrifuged for six minutes
at 1,300 rpm, the supernatant was removed, and the pellet was suspended in 1mL
deionized H2O (diH2O). After determining the cell population using a hemacytometer
(see section 4.2.4), the appropriate aliquots of cell suspension and diH2O were transferred
(see equation 4.2) into two sets of microcentrifuge tubes containing 0, 500, 1000, 2500,
5000, and 10000 cells respectively (total volume = 500µL). The ten standards were then
transported – along with the study samples designated for analysis – to the assay room.
All standards were centrifuged in the Eppendorf miniSpin (2000rpm for 6min),
rinsed in 500µL diH2O, and centrifuged again, while designated samples were rinsed
three times in 100µL diH2O. After the rinsing stages, standards and samples were soaked
in 100µL of 0.1% Triton X-100 in diH2O for one hour at RT. Next, each sample was
scraped for one minute using a pipette tip to dislodge any cells still attached to the
scaffold/plate and then transferred (100µL) to a 96-well black fluorescent plate. The
standards were pipetted thoroughly prior to transferring the 100µL suspensions. Lastly,
100µL of 1:200 PicoGreen Reagent in (1X TE Buffer) was added to each sample and
standard and allowed to incubate in darkness for at least three minutes. Absorbance levels
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were read using a FLX800 microplate fluorescence reader and KCjunior software (BioTck Instruments) (excitation=480nm, emission=520nm, sensitivity=50).

4.2.5 Cell Fixation via Paraformaldehyde
Each sample underwent a cell fixing procedure in order to “freeze” the cells at their
designated observation time point. Each sample was removed from the incubator, rinsed
twice in PBS in sterile conditions, and transferred to the cell assay station. Afterwards,
100µL of 4% paraformaldehyde (Sigma-Alderich) diluted in PBS (pH=7.4) was then
added and allowed to incubate at RT for twenty minutes. The samples were then rinsed
twice in PBS, and soaked in 100µL of 0.1% Triton X in PBS for five minutes in order to
permeablize the membrane for immunoassays. Finally, the samples were rinsed in PBS
and were either wrapped in Parafilm® to be stored at 4°C, or set aside for cell stainings.

4.2.6 Cell Staining for Actin Filaments
This cytoskeletal staining was performed on samples containing either BCC or MSC cell
types. Fixed, permeablized samples (Section 4.2.5) were soaked in 100µL of 1:100
rhodamine phalloidin (Invitrogen) in PBS for one hour at RT in darkness. They were then
rinsed in PBS, wrapped in Parafilm®, and stored at 4°C to wait for analysis.

4.2.7 DAPI Nuclear Stain
The DAPI protocol for this study followed a near-identical procedure used in the in vivo
bone regenerative analysis (Sub-subsection 3.2.1.3).
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4.2.8 Confocal Microscopy
Stained samples were illuminated using three diode lasers with excitation values of 405
(blue), 488 (green), and 561 (red) nanometers. Images were recorded at either 20x or 40x
magnification using NIS-Elements AR 3.2 software (Nikon). Each recorded image
represents a compilation of confocal images of planes taken at various depths in the
sample (z-stack) in order to render a clearer unobstructed view of a three-dimensional
structure.
4.2.9 Statistical Analysis
All quantitative data underwent statistical processing identical to the methods discussed
in the previous chapter/study (Section 3.2.3).

4.3

Results and Discussion

This section details the results for all experiments performed with the in vitro study.
Discussed are the results for scaffold fabrication via electrospinning, both the BCC and
MSC attachment to scaffold, cellular morphologies, and the cell viability of MSC-seeded
scaffolds.

4.3.1 Scaffold Characterization
Eight different scaffolds were constructed for these series of experiments, varying in fiber
orientation as well as composition. A 15%wt PCL in MC solution yielded two scaffold
types – random and aligned fibrous mats. Random and aligned fiber scaffolds were also
constructed from three composite materials obtained from solutions of 10%wt polymer
PCL in MC combined with 30%wt ceramics of HA, β-TCP, and 20/80 ratio HA/β-TCP,
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respectively. SEM imaging at 500X, 1000X, and 2500X revealed the fibrous micro and
nanostructures for each scaffold configuration and type (Figure 4.4-5).

Figure 4.4 SEM images taken at 500X, 1000X, and 2500X, respectively for PCL (A-C),
PCL+HA (D-F), PCL+β-TCP (G-I), and PCL+β-TCP/HA (J-L) aligned fiber mats.
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Figure 4.5 SEM images taken at 500X, 1000X, and 2500X, respectively for PCL (A-C),
PCL+HA (D-F), PCL+β-TCP (G-I), and PCL+β-TCP/HA (J-L) random fiber mats.

Overall, the fibers for PCL random and aligned oriented mats are remarkably
smoother in surface contours compared the composite scaffolds, where large ceramic
granules are observed along the individual strands. These results are to be expected, as
the ceramic nanoparticles tend to clump together when in solution despite the sonification
process prior to spinning. This clumping in the composite mats also resulted in more
variability in determining the fiber diameter. In Addition, for aligned fiber mats
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containing β-TCP, there was an observable difference in the alignment compared to other
aligned mat types. According to previous research, this could be attributed to residual
charges left within the spun fibers on the collecting wheel [61, 62]. These charges, in
turn, polarize the entire scaffold and deflect the ideal fiber alignment during the
collection process. A visual observation during the electrospinning procedure noted the
repellence of the electrospun fibers attempting to collect onto the grounded wheel, and
instead deflecting back towards the syringe. This phenomenon appeared to be more
typical as time went on and as the fibers continued to accumulate.
The average fiber diameters for each scaffold were calculated using the 1000X
images (n=80) (Table 4.3). These measurements suggest with a 95% level of confidence
that the true mean Df of the scaffolds used in the series of experiments falls within these
margins; however, the results are based upon the fabrication of only four scaffolds. The
claim can be made that based upon sample size (n=4) the fiber diameters and alignments
for all scaffold types are statistically similar.
Table 4.3 Fiber Diameters (Df) and Degree of Alignment for Electrospun Scaffolds
Fiber Type
Random

Aligned

Components
PCL
PCL + HA
PCL + β-TCP
PCL + HA/β-TCP
PCL
PCL + HA
PCL + β-TCP
PCL + HA/β-TCP

Df (µm)
9.54±2.23
9.10±3.21
7.39±2.37
7.99±3.23
8.86±2.13
9.92±2.93
6.92±2.33
9.06±2.92

Alignment (%)

95.41±4.78
95.90±3.27
91.04±8.76
94.86±4.70

Df = average ± standard deviation; fiber alignment calculated for aligned mats only; *PCL+β-TCP aligned
electrospun mats had slightly smaller Df compared to other aligned mats, but none of statistical significance
(p<0.05).

The fiber diameters are influenced by a variety of factors such as viscosity, the
voltage (V), flow rate (Q), and needle size [63]. For the case of PCL+β-TCP aligned fiber
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scaffolds, a slight differences in Df were noticed compared to other aligned mats, but not
enough for any statistical significance (p<0.05). Slight differences would not be
unexpected since although since β-TCP is less soluble compare to HA, which would
result in a less uniform solution and create variability within the fiber strands. This nonuniformity could also affect the alignment of fibers. As discussed above, the resulting
residual charge created by the electrospinning process could also lead to bends and loops
within the fibrous scaffold. More exhaustive testing would need to be performed in order
to increase the sample size and lower the variability in the standard deviations, creating a
more reliable test statistic. In addition, methods of solution preparation need to be more
effective towards creating a homogenous solution with minimal ceramic aggregates.

4.3.2 BCC Attachment and Morphology
Both BCC-lines were both exposed to the nuclear DAPI stain, and phalloidin was applied
to highlight the cell morphology using actin filaments. Confocal images were then taken
at 40x magnification of each cell type on every scaffold, for all time points (Figures 4.64.7). For composite scaffolds (Figures 4.6-7:B,C,F,G), ceramic debris can be seen,
appearing as reddish blobs that indicate aggregates within the fibers. This is to be
expected, as SEM imaging also confirms the non-uniformity when using ceramic
components. Also as expected, scaffolds comprised of β-TCP portray more aggregates
than composites containing only HA (Figure 4.7C,G) since β-TCP is known to be less
soluble.
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Figure 4.6 Confocal images taken at 40x magnification on day 1 (A-D) and 4 (E-H) of
MD cells with Oct4-Hi expression seeded on PCL, PCL+HA, PCL+β-TCP, and aligned
PCL scaffolds respectively. Nuclear-stain DAPI (blue) is surrounded by the cell’s actin
filaments (red) and GFP-Oct4 (green); scaffold debris is also seen (red).

Figure 4.7 Confocal images taken at 40x magnification on day 1 (A-D) and 4 (E-H) of
MD cells with Oct4-Lo expression seeded on PCL, PCL+HA, PCL+β-TCP, and aligned
PCL scaffolds respectively. Nuclear-stain DAPI (blue) is surrounded by the cell’s actin
filaments (red) and GFP-Oct4 (green); scaffold debris is also seen (red).

Perhaps the most interesting observation within the BCC images is the expression
of the OCT4-GFP. In samples containing Oct4-Hi BCCs (Figure 4.6), traces of OCT-4
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can be seen at day 1; however, by day 4 the samples containing PCL only (images E and
H) showed no OCT-4 expression, suggesting that the BCCs were becoming more
aggressive. The same scenario holds true even for Oct4-Lo BCCs (Figure 4.8), where day
4 confocal images show OCT4-GFP for ceramic composite scaffolds, but not for PCL
alone. This observation is highly important for Oct4-Lo cells since the emergence of
OCT-4 signifies BCCs entering a state of dormancy. Therefore, it can be suggested that
composite scaffolds containing polymer and ceramic components support the less
aggressive Oct4-Hi BCCs, which is necessary in studying breast cancer dormancy.

4.3.3 MSC Attachment and Morphology
Two confocal images were captured for each sample at every time point, which
highlights the cell nuclei (blue), actin filaments (red), and scaffold fibers that are picked
up in the background noise. The 488nm (green) laser was not necessary for this study, as
no antibodies fluoresced at that wavelength. The following compilation of images
(Figures 4.8-12) provides only an examination of the seeded cells, and they are not an
accurate example of the scaffold as a whole. This could be attributed to specific methods
described within the cell seeding protocol in which the cell suspension was pipetted onto
a localized area of the scaffold sitting in general media, which was not mixed uniformly
afterwards. Therefore, in day 1 samples, MSCs appeared numerous in selective locations
while being absent entirely from others on a given scaffold.
In Figures 4.8-4.11, drastic differences in actin filaments were observed between
random (A-D) and the aligned (E-H) fiber mats. In confocal images of randomly oriented
scaffolds, actin filaments were not as pronounced, particularly at day 1. At days 7 and 14,
MSCs were given more time to form attachments and elongate on the scaffolds. As a
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result, the actin began to branch out into box-like structures that filled the inter-fiber
spacings, and formed attachments to adjacent fibers.
In the images containing aligned fiber scaffolds (Figures 4.8-11:E-H), the actin
appeared to take on a more unified role. As early as day 1, actin filaments began to
stretch, indicating cell elongation along the fibers. Previous literature suggests a
connection between observed cell elongation and cell migration [13, 14]. This process
ultimately would prove useful in the guidance of bone formation as well as the formation
of aligned mineralized collagen fibrils, which make up the majority of bone. For images
containing ceramic components (Figures 4.9-4.11), HA and β-TCP particles were picked
up by the red confocal laser, which add to the background noise. They are typically seen
as globular masses which follow the same patterning trend as the electrospun fibers.
Lastly, the tissue-plated samples that act as the controls for the experiments (Figure 4.12)
quickly formed a confluent monolayer by day 7, forming laterally-wide flattened actin
filaments clinging to the surface of the culture-treated well. This result was expected
since the cells could only attach in one dimension as opposed to the porous architecture
created by the fibers. On day 4 of the control (Figure 4.12D) the actin self-oriented into
an aligned pattern.
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Figure 4.8 Confocal images taken at 20x of MSCs seeded on random PCL (A-D) and
aligned PCL (E-H) scaffolds at days 1, 4, 7, and 14, respectively.

Figure 4.9 Confocal images taken at 20x of MSCs seeded on random PCL+HA (A-D)
and aligned PCL+HA (E-H) scaffolds at days 1, 4, 7, and 14, respectively.

49

Figure 4.10 Confocal images taken at 20x of MSCs seeded on random PCL+β-TCP (AD) and aligned PCL+β-TCP (E-H) scaffolds at days 1, 4, 7, and 14, respectively.

Figure 4.11 Confocal images taken at 20x of MSCs seeded on random PCL+β-TCP/HA
(A-D) and aligned PCL+β-TCP/HA (E-H) scaffolds at days 1, 4, 7, and 14, respectively.

Figure 4.12 Confocal images taken at 20x of MSCs seeded on tissue culture plates
(control) at days 1, 4, 7, and 14, respectively.
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4.3.4 MSC Proliferation Assay
At times points day 1, 4, 7, and 14, MSCs seeded at 1000cells/sample onto each scaffold
(n=4) were analyzed to determine the population count by following the PicoGreen Assay
protocol (Section 4.2.4). The results were then calculated based upon the plate readouts
and generated standard curves, and the values were graphed depicting the rate of growth
for each scaffold over a two week period. Figures 4.13-4.16 show an overlaid comparison
between aligned and random fiber oriented scaffolds for each composition; the computed
standard deviations were included as error bars to demonstrate the variability of each
value. Statistical analysis revealed significantly higher cell counts for random fiber mats
compared to aligned fiber mats at days 1 and 4 for all compositions. This difference,
primarily at day 1, suggests that initial cell attachment is favorable for random fiber mats.
This result could be based upon several factors such as interfiber spacing, cell seeding
errors, and the ability for cells to penetrate the scaffolds. If fiber spacing is too small,
then cells may not have enough surface area to attach or penetrate the scaffold surface.
The control is shown, both on its own (Figure 4.17) and overlaid with the
PicoGreen data for all scaffold compositions and types (Figure 4.18). Figure 4.19
provides a closer comparison of MSCs seeded on all scaffolds by removing the control
data. At days 1, 4, and 7, all random fiber scaffolds recorded high cell populations in
comparison to aligned fiber-oriented scaffolds of the same material composition. This
difference appears most prominent at day 1, indicating differences in initial cell
attachment to the scaffold. At day 14 (week 2), aligned fiber scaffolds containing β-TCP
were noted as having high cell numbers than their aligned counterparts, however, the
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overlapping within the standard deviations prevents any significant conclusions from
being drawn. Control MSCs grown on treated tissue culture plates experienced a sharp
incline between day 7 and 14 with minimal deviation according to the charted data. At
this point, it is important to note that time-points on the horizontal x-axis are not
proportionately distributed; therefore, the visual representation of the line graph between
day 7 and 14 is intrinsically slightly distorted.
Several data points in the results did not fit the expected trends for the
experiment. For example, in day 14 of the random scaffolds containing β-TCP, and
particularly the aligned PCL scaffold, there was a decrease observed in the cell
population count. In addition, as previously mentioned (Section 4.3.3) the cells were not
seeded uniformly onto the scaffolds, but rather were transferred from a condensed
suspension onto a localized area of the scaffold. This could potentially have created
experimental errors in the cell attachments and lead to larger variances within the data.
Overall, repeated testing is needed in order to confirm the validity of these results.
Furthermore, sequential research would investigate behaviors such as MSC osteogenic
behavior using well-known protein markers such as alkaline phosphatase and calcium. If
certain scaffolds were found to induce osteogenesis in MSCs at an earlier stage, then the
proliferation assays could be affected, since cell growth ceases at the point of
differentiation.
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Figure 4.13 Graph comparing MSC cell counts for aligned (red) versus random (blue)
fiber PCL scaffolds.

Figure 4.14 Graph comparing MSC cell counts for aligned (red) versus random (blue)
fiber PCL+HA scaffolds.
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Figure 4.15 Graph comparing MSC cell counts for aligned (red) versus random (blue)
fiber PCL+β-TCP scaffolds.

Figure 4.16 Graph comparing MSC cell counts for aligned (red) versus random (blue)
fiber PCL+β-TCP/HA scaffolds.

54

Figure 4.17 Graph displaying MSC cell counts for control group seeded on a culturetreated plate.

Figure 4.18 Graph displaying MSC cell population counts for all seeded samples.
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Figure 4.19 Graph of MSC cell population counts for scaffolds only (no control).
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CHAPTER 5
CONCLUSION

The two main experiments, although different in their designed purpose, both
demonstrate practical applications for bone tissue engineering techniques. Whether the
intended goal is to advance tissue regeneration in orthopaedic surgeries, or to design a
construct capable of examining cellular interactions, tissue engineering strategies can be
developed in order to meet the needs and specifications.
Extensive immunohistochemical analysis revealed intriguing results for the in
vivo VAC therapy study on the New Zealand rabbit subjects. Semi-quantitative results
indicated significantly improved rates of tissue regrowth (via BrdU expression) in week 1
subjects who received the experimental VAC treatment. Furthermore, ALP analysis
suggests superior osteoconductive behavior compared to rabbits who did not receive the
treatment. Therefore, vacuum-assisted wound closure could hold promise in orthopaedic
surgical procedures as a method to promote tissue and bone regrowth. Further preclinical
trials would need to be conducted in order to more definitively validate these findings
before moving forward to clinical experiments in human patients. Furthermore, since the
particular secondary treatment involving the porous ceramic scaffold was not favorable
with VAC therapy, other orthopedic treatments could be tested for use in combination for
surgeries.
Significant progress was also made in creating a viable tissue-engineered
biomimetic bone scaffold for both MSCs and BCCs; however, more groundwork still
needs to be laid concerning cell viability. Results did indicate favorability for Oct4-Hi
BCCs towards composite scaffolds, which is preferable for studying BCC dormancy.
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Further research would test the biocompatibility of BCCs all aligned composite scaffold
compositions prior to a main investigative study examining the intracellular mechanisms
between the two cell lines. In addition, the intrinsic osteogenic properties of the scaffolds
needs to be tested utilizing an osteoinductive media in order to better initiate the
differentiation process that would naturally occur within the body. Methods also need to
be developed in which to simultaneously visualize markers for both cell types, their
structures, and other potential protein markers. Lastly, fabrication methods need to be
refined in order to create scaffolds with better alignment (particularly for ceramic
scaffolds) and with high levels of fiber uniformity.
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